- the management of genitourinary malignancies, with a focus on prostate and testicular cancer
- drug discovery and development
Professor Christopher Sweeney is the inaugural Director of the South Australian immunoGENomics Cancer Institute (SAIGENCI) at the University of Adelaide.
He received his medical degree from the University of Adelaide and completed an internship at the Royal Adelaide Hospital. Professor Sweeney did his residency in internal medicine at Gundersen Lutheran Medical Center (Wisconsin, USA) and a fellowship in hematology/oncology at Indiana University Medical Center (Indiana, USA), where he was later appointed Associate Director for Clinical Research for the Simon Cancer Center. Professor Sweeney joined the Lank Center for Genitourinary Oncology at the Dana-Farber Cancer Institute and Harvard Medical School (Massachusetts, USA) in 2009. He was promoted to Full Professor at Harvard University in 2018 and returned to Australia in 2022.
His primary research interest is drug discovery and development. His academic focus is primarily on the management of genitourinary malignancies, with a focus on prostate and testicular cancer.Back to Our People